{"disease":{"id":"systolic-heart-failure-stage-d-disorder","name":"systolic heart failure stage d disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04217135","title":"The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Kaohsiung Veterans General Hospital.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}